Palomar Gets $31 Million as Syneron Ends Hair-Removal Case
This article is for subscribers only.
Palomar Medical Technologies Inc., a maker of cosmetic lasers, said it will receive $31 million plus royalties from Syneron Medical Ltd. in a settlement of their patent-infringement dispute over hair-removal systems.
Syneron and its Candela unit will get a license to Palomar technology for professional hair-removal systems, and will pay royalties for home-use products, the companies said today in a statement. Palomar will also get a license to some Syneron patents.